Cellular changes in Nevus associated Melanoma

Cellular changes in Nevus associated Melanoma - scRNAM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030883

Enrollment

Registered

2022-12-30

Start date

2022-12-30

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43.9

Interventions

Group 1: Patients with pigment lesions that are supsicious for malignant melanoma will be included. Our goal is to characterize the molecular changes that occur when cells transition from a benign ne

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - suspected (premalignant) nevus associated Melanoma - dated and signed informed consent form

Exclusion criteria

Exclusion criteria: - patient wish - immunocompromised patients - participation in another study

Design outcomes

Primary

Measure	Time frame
Characterization of molecular changes of tumor cells at the transition between benign melanocytic nevi and malignant melanoma.	—

Secondary

Measure	Time frame
Characterization of molecular changes of cells of the tumor microenviromnet at the transition between benign melanocytic nevi and malignant melanoma.	—

Countries

Germany

Contacts

Public ContactRose K.C. Moritz

Charité- Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie

rose.moritz@charite.de+4930450518041

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026